| I-004 Jurij Aguiar Zdovc Population pharmacokinetic-pharmacodynamic analysis of elafibranor and metabolite GFT1007 to support exposure-response characterization and dose selection in patients with primary biliary cholangitis Wednesday 10:20-11:50 |
| I-004 Jurij Aguiar Zdovc Population pharmacokinetic-pharmacodynamic analysis of elafibranor and metabolite GFT1007 to support exposure-response characterization and dose selection in patients with primary biliary cholangitis Wednesday 10:20-11:50 |